EHTH
eHealth, Inc.
NasdaqGSUSDEQUITY
Financial Services
DELAYED
Sell
-49/100
Last price
0.76
▲ 0.08 (11.45%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.68
Day high
0.77
Day low
0.69
Volume
573.00K
Market cap
$24.10M
P/E (TTM)
—
52W range
0.65 – 5.89
Trailing performance
Returnvs SPY
1W
+5.56%
+3.6%
1M
-23.23%
-24.4%
3M
-52.80%
-57.3%
6M
-47.22%
-65.4%
YTD
-83.48%
-97.7%
1Y
-82.88%
-99.3%
3Y
-89.73%
-172.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EHTH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+552.69K
Net buying
Buy transactions
10
627.29K shares
Sell transactions
1
74.59K shares
Net transactions
+11
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
2.44M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 1, 26 | SOISTMAN FRANCIS S JR Director |
SELL | 74.59K | $81.71K | Direct |
| Sep 1, 26 | DOLAN JOHN JOSEPH Chief Financial Officer |
STOCK | 70.00K | $0 | Direct |
| Sep 1, 26 | GALIMI GAVIN G General Counsel |
STOCK | 60.00K | $0 | Direct |
| Sep 1, 26 | BARBEAU MICHELLE MARIE Officer |
STOCK | 70.00K | $0 | Direct |
| Jun 18, 26 | BROOKE BETH A Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | BHATT PRAMA Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | WOLF DALE B Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | SOISTMAN FRANCIS S JR Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | HASS A. JOHN III Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | RUSSELL ERIN L Director |
STOCK | 61.04K | $0 | Direct |
| Jun 18, 26 | ARDEN TODD W Director |
STOCK | 61.04K | $0 | Direct |
| Mar 18, 26 | DOLAN JOHN JOSEPH Chief Financial Officer |
STOCK | 73.50K | $0 | Direct |
| Mar 18, 26 | GALIMI GAVIN G General Counsel |
STOCK | 59.50K | $0 | Direct |
| Mar 18, 26 | BARBEAU MICHELLE MARIE Officer |
STOCK | 70.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARBEAU MICHELLE MARIE |
Officer | 374.46K | Stock Award(Grant) |
BHATT PRAMA |
Director | 140.48K | Stock Award(Grant) |
BROOKE BETH A |
Director | 193.87K | Stock Award(Grant) |
DOLAN JOHN JOSEPH |
Chief Financial Officer | 343.27K | Stock Award(Grant) |
DUKE DERRICK A. |
Chief Executive Officer | 487.97K | Purchase |
GALIMI GAVIN G |
General Counsel | 335.04K | Stock Award(Grant) |
HASS A. JOHN III |
Director | 182.93K | Stock Award(Grant) |
RUSSELL ERIN L |
Director | 176.08K | Stock Award(Grant) |
SOISTMAN FRANCIS S JR |
Director | 1.02M | Sale |
WOLF DALE B |
Director | 247.11K | Stock Award(Grant) |
Fundamentals
Market cap$24.10M
Enterprise value$461.73M
Revenue (TTM)$501.69M
Gross profit$501.69M
EBITDA$63.21M
Net income$-26.27M
EPS (TTM)$-0.79
Free cash flow$43.35M
Total cash$101.05M
Total debt$132.17M
Book value / share$17.36
Shares outstanding31.74M
Float25.71M
Short % of float1.38%
Dividend yield0.00%
Beta (5Y)1.63
Valuation & profitability ratios
Trailing P/E—
Forward P/E0.60
PEG ratio0.75
Price / sales—
Price / book0.04
EV / revenue0.92
EV / EBITDA7.31
Gross margin100.00%
Operating margin-81.62%
Profit margin5.42%
Return on equity2.92%
Return on assets3.42%
Debt / equity13.96
Current ratio9.95
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $554.01M | $532.41M | $452.87M | $405.36M | — | +4.1% |
| Operating revenue | $497.95M | $461.65M | $403.92M | $361.25M | — | +7.9% |
| Cost of revenue | — | $1.79M | $1.77M | $1.65M | $1.99M | — |
| Gross profit | — | $530.62M | $451.10M | $403.71M | $536.21M | — |
| Research & development | — | — | — | — | $83.80M | — |
| Selling, general & admin | $270.80M | $282.40M | $272.00M | $266.90M | — | -4.1% |
| Total operating expense | $485.51M | $499.36M | $480.17M | $486.81M | — | -2.8% |
| Operating income | $68.50M | $33.05M | -$29.07M | -$83.10M | — | +107.3% |
| Net interest income | -$10.76M | -$11.16M | -$10.97M | -$7.63M | — | +3.6% |
| Pre-tax income | $58.73M | $19.31M | -$30.59M | -$106.39M | — | +204.1% |
| Tax provision | $18.68M | $9.26M | -$2.38M | -$17.67M | — | +101.9% |
| Net income | $40.04M | $10.06M | -$28.21M | -$88.72M | — | +298.2% |
| Net income to common | -$10.40M | -$34.96M | -$66.52M | -$119.41M | — | +70.2% |
| Basic EPS | -0.34 | -1.19 | -2.37 | -4.36 | — | +71.4% |
| Diluted EPS | -0.34 | -1.19 | -2.37 | -4.36 | — | +71.4% |
| EBIT | $69.49M | $30.47M | -$19.62M | -$98.76M | — | +128.0% |
| EBITDA | $83.25M | $46.81M | $295.00K | -$77.65M | — | +77.8% |
| Basic shares | 30.48M | 29.34M | 28.02M | 27.36M | — | +3.9% |
| Diluted shares | 30.48M | 29.34M | 28.02M | 27.36M | — | +3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $73.72M | $39.20M | $115.72M | $144.40M | — | +88.1% |
| Cash & short-term investments | $77.22M | $82.24M | $121.65M | $144.40M | — | -6.1% |
| Accounts receivable | $7.69M | $16.81M | $3.99M | $2.63M | — | -54.3% |
| Total current assets | $334.35M | $354.48M | $382.35M | $401.08M | — | -5.7% |
| Property, plant & equipment | $12.96M | $16.52M | $27.63M | $32.02M | — | -21.5% |
| Goodwill & intangibles | — | — | — | — | $1.92M | — |
| Total assets | $1.26B | $1.16B | $1.11B | $1.11B | — | +9.3% |
| Total current liabilities | $99.07M | $96.01M | $78.54M | $60.56M | — | +3.2% |
| Long-term debt | $112.95M | $68.46M | $67.75M | $66.13M | — | +65.0% |
| Total debt | $134.35M | $96.92M | $103.16M | $106.80M | — | +38.6% |
| Total liabilities | $670.87M | $567.00M | $507.31M | $461.66M | — | +18.3% |
| Retained earnings | $30.12M | $15.25M | $7.28M | $73.80M | — | +97.5% |
| Shareholder equity | $591.60M | $588.43M | $606.03M | $650.96M | — | +0.5% |
| Working capital | $235.28M | $258.46M | $303.81M | $340.52M | — | -9.0% |
| Net tangible assets | $591.60M | $588.43M | $606.03M | $650.96M | — | +0.5% |
| Shares issued | 44.80M | 43.23M | 41.46M | 39.98M | — | +3.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $40.04M | $10.06M | -$28.21M | -$88.72M | +298.2% |
| Depreciation & amortisation | $13.76M | $16.34M | $19.92M | $21.11M | -15.8% |
| Stock-based compensation | $15.04M | $19.88M | $23.21M | $20.32M | -24.3% |
| Change in working capital | -$114.86M | -$81.73M | -$19.64M | $24.68M | -40.5% |
| Operating cash flow | -$25.34M | -$18.37M | -$6.69M | -$26.87M | -38.0% |
| Capital expenditure | -$15.31M | -$12.86M | -$10.78M | -$15.51M | -19.1% |
| Investing cash flow | $25.43M | -$48.42M | -$15.89M | $25.86M | +152.5% |
| Share buybacks | -$2.44M | -$3.41M | -$3.33M | -$3.10M | +28.5% |
| Dividends paid | -$5.90M | -$5.56M | -$3.53M | $0 | -6.1% |
| Financing cash flow | $34.29M | -$9.67M | -$6.22M | $63.84M | +454.4% |
| Free cash flow | -$40.65M | -$31.22M | -$17.47M | -$42.38M | -30.2% |
| End cash position | $76.81M | $42.29M | $118.81M | $147.64M | +81.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $33.57M | $88.02M | $326.24M | $53.87M | $60.78M | -61.9% |
| Operating revenue | $29.80M | $79.81M | $297.06M | $47.22M | $54.73M | -62.7% |
| Selling, general & admin | $27.36M | $40.91M | $122.97M | $46.32M | $43.01M | -33.1% |
| Total operating expense | $60.96M | $84.52M | $199.98M | $94.94M | $82.27M | -27.9% |
| Operating income | -$27.40M | $3.49M | $126.26M | -$41.07M | -$21.49M | -884.1% |
| Net interest income | -$4.05M | -$4.04M | -$3.38M | -$2.38M | -$2.35M | -0.5% |
| Pre-tax income | -$30.68M | -$6.07M | $121.98M | -$42.93M | -$24.05M | -405.2% |
| Tax provision | -$7.08M | -$1.36M | $34.80M | -$11.24M | -$6.65M | -421.3% |
| Net income | -$23.59M | -$4.71M | $87.18M | -$31.69M | -$17.40M | -400.5% |
| Net income to common | -$37.51M | -$18.11M | $73.93M | -$44.58M | -$29.78M | -107.2% |
| Basic EPS | -1.18 | -0.58 | 2.13 | -1.46 | -0.98 | -103.4% |
| Diluted EPS | -1.18 | -0.58 | 2.06 | -1.46 | -0.98 | -103.4% |
| EBIT | -$26.63M | -$2.04M | $125.36M | -$40.55M | -$21.70M | -1,206.4% |
| EBITDA | -$23.33M | $1.22M | $128.58M | -$37.41M | -$18.23M | -2,012.6% |
| Basic shares | 31.78M | 31.13M | 30.89M | 30.63M | 30.40M | +2.1% |
| Diluted shares | 31.78M | 31.13M | 32.02M | 30.63M | 30.40M | +2.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $69.68M | $75.11M | $73.72M | $63.09M | $65.92M | — | -7.2% |
| Cash & short-term investments | $101.05M | $110.81M | $77.22M | $75.30M | $105.20M | — | -8.8% |
| Accounts receivable | $1.82M | $1.54M | $7.69M | $1.85M | $1.86M | — | +18.3% |
| Total current assets | $315.75M | $336.61M | $334.35M | $302.87M | $328.17M | — | -6.2% |
| Property, plant & equipment | $11.02M | $12.24M | $12.96M | $14.12M | $15.25M | — | -10.0% |
| Total assets | $1.16B | $1.20B | $1.26B | $1.05B | $1.08B | — | -3.6% |
| Total current liabilities | $31.75M | $44.35M | $99.07M | $51.24M | $110.20M | — | -28.4% |
| Current debt | — | — | — | — | $69.09M | $68.77M | — |
| Long-term debt | $114.61M | $113.76M | $112.95M | $69.42M | — | — | +0.7% |
| Total debt | $132.17M | $133.20M | $134.35M | $92.73M | $93.76M | — | -0.8% |
| Total liabilities | $617.23M | $625.38M | $670.87M | $162.95M | $165.88M | — | -1.3% |
| Retained earnings | -$11.59M | $12.01M | $30.12M | -$43.81M | -$12.12M | — | -196.5% |
| Shareholder equity | $540.80M | $575.73M | $591.60M | $884.47M | $913.83M | — | -6.1% |
| Working capital | $284.00M | $292.26M | $235.28M | $251.63M | $217.97M | — | -2.8% |
| Net tangible assets | $540.80M | $575.73M | $591.60M | $884.47M | $913.83M | — | -6.1% |
| Shares issued | 31.95M | 45.00M | 44.80M | 44.42M | 44.14M | — | -29.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$23.59M | -$4.71M | $87.18M | -$31.69M | -$17.40M | -400.5% |
| Depreciation & amortisation | $3.29M | $3.26M | $3.21M | $3.14M | $3.47M | +1.0% |
| Stock-based compensation | $2.33M | $2.26M | $3.46M | $3.92M | $3.88M | +3.2% |
| Change in working capital | $19.28M | $36.14M | -$167.21M | $10.63M | -$24.51M | -46.6% |
| Operating cash flow | -$4.96M | $35.77M | -$35.95M | -$25.31M | -$41.20M | -113.9% |
| Capital expenditure | -$2.68M | -$2.31M | -$2.42M | -$3.62M | -$5.84M | -16.4% |
| Investing cash flow | $1.93M | -$34.36M | $6.38M | $23.70M | -$10.12M | +105.6% |
| Share buybacks | -$48.00K | -$160.00K | -$337.00K | -$276.00K | -$1.13M | +70.0% |
| Dividends paid | — | — | -$2.99M | $0 | — | — |
| Financing cash flow | -$3.03M | -$160.00K | $40.11M | -$1.28M | -$3.84M | -1,793.1% |
| Free cash flow | -$7.64M | $33.46M | -$38.37M | -$28.94M | -$47.05M | -122.8% |
| End cash position | $72.31M | $78.20M | $76.81M | $66.18M | $69.01M | -7.5% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
+229.3% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
1
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -1.17 | -1.18 | -0.5% |
| Mar 2026 | -0.83 | -0.58 | +30.1% |
| Dec 2025 | 2.38 | 2.06 | -13.6% |
| Sep 2025 | -1.81 | -1.46 | +19.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.46 | 3 | $27.10M | -49.7% |
| Next quarter | 1.91 | 3 | $273.74M | -16.1% |
| Current year | -1.27 | 3 | $422.43M | -23.8% |
| Next year | -0.98 | 3 | $435.25M | +3.0% |
Analyst targets & ownership
Mean target$1.81
High target$2.00
Low target$1.50
Implied upside138.71%
Analyst count4
ConsensusNONE
Strong buy / Buy0 / 0
Hold5
Sell / Strong sell0 / 0
Held by insiders7.61%
Held by institutions51.11%
Institutions holding136
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.74
+2.89% from price
SMA 20
0.82
-6.92% from price
SMA 50
1.05
-27.85% from price
SMA 100
1.33
-42.76% from price
SMA 200
1.83
-58.38% from price
EMA 12
0.76
-0.15% from price
EMA 26
0.86
-12.22% from price
EMA 50
1.02
-25.73% from price
RSI (14)
35.7
Neutral
MACD (12,26,9)
-0.10
Hist 0.00
ATR (14)
0.05
7.24% of price
Realised vol 30D
77.0%
Annualised
Bollinger upper
1.00
20, 2σ
Bollinger lower
0.64
20, 2σ
50 / 200 cross
Death
1.05 vs 1.83
Trend bias
Below 200
-58.38%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.44
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
77.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-88.1%
Peak to trough
Max drawdown 5Y
-98.6%
Peak to trough
ATR 14
0.05
7.24% of price
Beta (reported)
1.63
5Y monthly, from filing
Short interest
Shares short
414.36K
Prior 569.18K
Change vs prior
-27.2%
Shorts covering
% of float
1.38%
Normal
% of shares out
1.29%
Against total outstanding
Days to cover
1.4
Liquid
Float
25.71M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 5, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Mar 11, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Feb 26, 26 | Craig-Hallum | DOWNGRADE | Buy | Hold |
| Nov 25, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Aug 7, 25 | UBS | MAINTAINED | Neutral | Neutral |
| May 19, 25 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| May 8, 25 | UBS | MAINTAINED | Neutral | Neutral |
| Dec 4, 24 | UBS | INITIATED | — | Neutral |
| Nov 25, 24 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Nov 6, 24 | Craig-Hallum | UPGRADE | Hold | Buy |
| Aug 14, 24 | Deutsche Bank | MAINTAINED | Hold | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-25
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEF 14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-03-31
Periodic Financial Reports
10-K · 2026-02-26
Headlines
eHealth Earns 2026-27 Great Place to Work Certification™, Marking Three Consecutive Years of Recognition for Employee Experience
PR Newswire · 5d ago
eHealth Taps BerniePortal Network to Drive CHOICE Enrollment
Zacks · 13d ago
eHealth Collaborates with a Top 3 Medicare Carrier to Support Medicare Advantage Plan Selection and Enrollment for the Upcoming Annual Enrollment Period
PR Newswire · 13d ago
eHealth Partners with BerniePortal to Provide Integrated CHOICE Arrangements for Employers and Brokers
PR Newswire · 14d ago
Employer Health Costs Surge: What it Means for EHTH, CNC & UNH
Zacks · 19d ago
Survey: 54% of Small- to Mid-Sized Businesses Report Double-Digit Health Plan Premium Increases for 2027
PR Newswire · 21d ago
ERS 2026: Objective nighttime cough data linked to subsequent asthma symptom severity, Albus Health reports
PR Newswire · 23d ago
Medicare Decoded: What to Know Before You Turn 65
TheStreet · 35d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.